Defense Health Program Department of Defense Chronic Pain Management Research Program Funding Opportunities for Fiscal Year 2020 (FY20)

How to Apply: 

The FY20 Defense Appropriations Act provides funding to the Department of Defense Chronic Pain Management Research Program (CPMRP) to support research of exceptional scientific merit with the potential to make a significant impact on improving the health and quality of life of Service members, Veterans, and all Americans living with chronic pain.  Per the FY19 CPMRP Congressional appropriation, chronic pain is defined as a pain that occurs on at least half the days for six months or more, and which can be caused by issues including, but not limited to:  combat- and training-related physical or mental stress and trauma, migraines and chronic headaches, traumatic brain injury, arthritis, muscular-skeletal conditions, neurological disease, tick and vector-borne disease, other insect-transmitted or tropical disease, and cancer.  The CPMRP seeks to support and promote innovative, high-impact research to prevent the development and improve the management of chronic pain, with specific emphasis on the utilization and implementation of non-opioid therapies or non-addictive complementary methods.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

 

The FY20 CPMRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website 

 

Applications submitted to the FY20 CPMRP award mechanisms must address one or more of the FY20 CPMRP Focus Areas.

 

  • Investigator-Initiated Research Award
    • Chronification of pain (i.e., the acute-to-chronic pain transition)
    • Development of novel non-µ-opioid receptor targeted therapies for the treatment of chronic pain
  • Translational Research Award
    • Comparative effectiveness (for evidence-based, efficacious interventions to manage chronic pain)
    • Implementation science (for evidence-based, efficacious interventions to manage chronic pain)

https://cdmrp.army.mil/funding/cpmrp

 

Investigator-Initiated Research Award – Preproposal due August 7, 2020

Investigators at or above the level of Assistant Professor (or equivalent)

  • Supports innovative research that will make an original and important contribution to the field of research, patient care, and/or quality of life in one of the FY20 CPMRP IIRA Focus Areas of Chronification of pain and Development of non-u-opioid receptor-targeted therapies and approaches.
  • Multidisciplinary collaborations and innovative approaches are encouraged.
  • Clinical trials will not funded.
  • Pre-application submission is required; application submission is by invitation only.
  • The maximum allowable funding for the entire period of performance is $900,000 for direct costs
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is years

 

Translational Research Award – Preproposal due August 7, 2020

Investigators at or above the level of Assistant Professor (or equivalent)

  • Supports translational research that will accelerate the movement of efficacious, evidence-based ideas into clinical applications.
  • Research must address one or both of the FY20 CPMRP TRA Focus Areas of Implementation science and Comparative effectiveness.
  • Effectiveness-implementation hybrid studies that incorporate biopsychosocial models of assessment are encouraged.
  • Studies seeking to evaluate new therapies or approaches, either pharmacological or non-pharmacological, that have not been previously evaluated in a clinical setting will not be funded.
  • Pre-application submission is required; application submission is by invitation only.
  • The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years

 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the CPMRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

 

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

External Deadline: 
Friday, August 7, 2020
Funding Source: 
External
Funding Level: 
Research